The Ensign Group, Inc. $ENSG Shares Sold by Royce & Associates LP

Royce & Associates LP cut its position in shares of The Ensign Group, Inc. (NASDAQ:ENSG) by 34.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,863 shares of the company’s stock after selling 2,582 shares during the quarter. Royce & Associates LP’s holdings in The Ensign Group were worth $840,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. CWM LLC lifted its position in The Ensign Group by 8.4% during the third quarter. CWM LLC now owns 732 shares of the company’s stock valued at $126,000 after buying an additional 57 shares in the last quarter. Profund Advisors LLC lifted its holdings in shares of The Ensign Group by 2.5% during the 3rd quarter. Profund Advisors LLC now owns 2,378 shares of the company’s stock valued at $411,000 after acquiring an additional 59 shares in the last quarter. UMB Bank n.a. boosted its position in The Ensign Group by 7.3% during the 3rd quarter. UMB Bank n.a. now owns 911 shares of the company’s stock worth $157,000 after purchasing an additional 62 shares during the period. First Horizon Advisors Inc. increased its holdings in The Ensign Group by 6.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 1,193 shares of the company’s stock valued at $184,000 after purchasing an additional 72 shares in the last quarter. Finally, HB Wealth Management LLC raised its position in The Ensign Group by 4.1% in the third quarter. HB Wealth Management LLC now owns 1,810 shares of the company’s stock valued at $313,000 after purchasing an additional 72 shares during the period. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages recently commented on ENSG. Truist Financial set a $215.00 target price on The Ensign Group and gave the company a “hold” rating in a report on Friday, February 6th. UBS Group set a $230.00 price target on The Ensign Group and gave the stock a “buy” rating in a report on Friday, February 6th. Royal Bank Of Canada reiterated an “outperform” rating and set a $222.00 price objective (up from $206.00) on shares of The Ensign Group in a research note on Monday, February 9th. Weiss Ratings restated a “buy (b)” rating on shares of The Ensign Group in a research note on Thursday, January 22nd. Finally, Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, The Ensign Group currently has an average rating of “Buy” and an average target price of $204.60.

Insider Activity

In other The Ensign Group news, Director Daren Shaw sold 1,000 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $213.43, for a total transaction of $213,430.00. Following the completion of the transaction, the director directly owned 23,726 shares of the company’s stock, valued at approximately $5,063,840.18. This trade represents a 4.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Suzanne D. Snapper sold 8,258 shares of The Ensign Group stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $194.48, for a total value of $1,606,015.84. Following the transaction, the chief financial officer owned 277,462 shares in the company, valued at approximately $53,960,809.76. This trade represents a 2.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 27,473 shares of company stock worth $5,167,422 in the last quarter. 3.90% of the stock is currently owned by corporate insiders.

The Ensign Group Stock Down 0.0%

ENSG opened at $207.23 on Friday. The Ensign Group, Inc. has a 12 month low of $118.73 and a 12 month high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.42 and a quick ratio of 1.42. The stock has a market cap of $12.00 billion, a P/E ratio of 35.48, a P/E/G ratio of 2.03 and a beta of 0.83. The stock’s 50 day moving average price is $190.75 and its 200 day moving average price is $181.50.

The Ensign Group (NASDAQ:ENSG) last announced its earnings results on Wednesday, February 4th. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.07. The Ensign Group had a return on equity of 16.76% and a net margin of 6.80%.The firm had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the previous year, the business earned $1.49 EPS. The firm’s revenue for the quarter was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. As a group, research analysts predict that The Ensign Group, Inc. will post 5.59 earnings per share for the current year.

The Ensign Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, January 31st. Shareholders of record on Wednesday, December 31st were given a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. This is a positive change from The Ensign Group’s previous quarterly dividend of $0.06. The ex-dividend date was Wednesday, December 31st. The Ensign Group’s payout ratio is currently 4.45%.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.